Alan Fujii: Clinical Trials

1 trial sponsored by Alan Fujii, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Terminated 1

Follow Alan Fujii: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Curosurf and Survanta Treatment(CAST)of RDS in Very Premature Infants
Survanta (beractant), Curosurf (poractant) - Prematurity, Respiratory Distress Syndrome
Phase 4TerminatedAlan Fujii522005-01-012011-10-03

Conditions studied

Ductus Arteriosus, Patent (1)  ·  Premature Birth (1)  ·  Respiratory Distress Syndrome (1)

Interventions

beractant (1)  ·  poractant alfa (1)

Countries

United States (1)

Top investigators

Alan M Fujii, MD (1)

Results publications

PMID 19956811, PMID 20336076, PMID 20336077